• Enveric Biosciences will participate in the BIO International Convention in San Diego on June 22-25, 2026.
• Management plans to hold meetings with potential strategic partners during the convention.
• The company highlighted progress on lead candidate EB-003, citing positive preclinical phototoxicity results and the start of IND-enabling GLP genotoxicity studies.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enveric Biosciences Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202606160928BIZWIRE_USPR_____20260616_BW833481) on June 16, 2026, and is solely responsible for the information contained therein.